Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hallmark DUAL: Asunaprevir and Daclatasvir in HCV Genotype 1b
NCT01581203Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of asunaprevir, daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started May 2012; status: completed.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01581203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581203.